Name : Arpita Hadimani(60Y/F)

Date : 20 Jan, 2026

Test Asked : Aarogyam C Pro With Utsh

Report Status : Complete Report

Processed At :
5CA-711, 3rd Floor, HRBR 2nd
Block, Hennur, Bengaluru-560043

Patient Name : ARPITA HADIMANI (60Y/F) Tests Done : AAROGYAM C PRO WITH UTSH
Referred By : DR PARAG MELAVANKI
Sample Collected At : (5800084401),Shravani clinic,Shravani clinic . 1 floor Sambrani billading.
580007,580008

Report Availability Summary

Note: Please refer to the table below for status of your tests.

12 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab

TEST DETAILS REPORT STATUS

AAROGYAM C PRO WITH UTSH Ready

CHLORIDE Ready

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) Ready

SODIUM Ready

TESTOSTERONE Ready

HBA PROFILE Ready

HEMOGRAM - 6 PART (DIFF) Ready

LIVER FUNCTION TESTS Ready

IRON DEFICIENCY PROFILE Ready

KIDPRO Ready

LIPID PROFILE Ready

T3-T4-USTSH Ready

VITAMIN D TOTAL AND B12 COMBO Ready

Processed At :
5CA-711, 3rd Floor, HRBR 2nd
Block, Hennur, Bengaluru-560043

Patient Name : ARPITA HADIMANI (60Y/F) Tests Done : AAROGYAM C PRO WITH UTSH
Referred By : DR PARAG MELAVANKI
Sample Collected At : (5800084401),Shravani clinic,Shravani clinic . 1 floor Sambrani billading.
580007,580008

Tests Outside Reference Range

Note: Please refer to the table below for tests outside reference range.

Test Name Observed Value Units Bio. Ref. Interval.

CARDIAC RISK MARKERS

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) 13.8 mg/L <3

COMPLETE HEMOGRAM
LYMPHOCYTES - ABSOLUTE COUNT 3.28 X 10³ / µL 1.0-3.0

MEAN [Link](MCHC) 28.8 g/dL 31.5-34.5

MEAN CORPUSCULAR HEMOGLOBIN(MCH) 24.9 pq 27.0-32.0

MONOCYTES 1.7 % 2-10

NEUTROPHILS - ABSOLUTE COUNT 8.6 X 10³ / µL 2.0-7.0

TOTAL LEUCOCYTES COUNT (WBC) 12.31 X 10³ / µL 4.0 - 10.0

TOTAL RBC 5.3 X 10^6/µL 3.8-4.8

HORMONE
TESTOSTERONE < 2.5 ng/dL 6 - 82

IRON DEFICIENCY
IRON 44.79 µg/dL 50 - 170

LIPID
HDL / LDL RATIO 0.37 Ratio > 0.40

LDL CHOLESTEROL - DIRECT 117 mg/dL < 100

TRIG / HDL RATIO 4.75 Ratio < 3.12

TRIGLYCERIDES 206 mg/dL < 150

VLDL CHOLESTEROL 41.22 mg/dL 5 - 40

LIVER
ALKALINE PHOSPHATASE 333.84 U/L 45-129

RENAL
BUN / [Link] RATIO 26.83 Ratio 9:1-23:1

CREATININE - SERUM 0.41 mg/dL 0.55-1.02

UREA / [Link] RATIO 57.41 Ratio < 52

VITAMIN
25-OH VITAMIN D (TOTAL) 13.1 ng/mL 30-100

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values, parameter correlation and clinical
interpretation, kindly refer to the same in subsequent pages.
Processed At :
5CA-711, 3rd Floor, HRBR 2nd
Block, Hennur, Bengaluru-560043

Patient Name : ARPITA HADIMANI (60Y/F) Sample Collected on (SCT) : 20 Jan 2026 22:16
: DR PARAG MELAVANKI Sample Received on (SRT) : 20 Jan 2026 23:13
Referred By
Sample Collected At : (5800084401),Shravani clinic,Shravani clinic . 1 floor Sambrani Report Released on (RRT) : 21 Jan 2026 03:17
billading. 580007,580008 Sample Type | Barcode : EDTA Whole Blood | FD495732

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c H.P.L.C 5.1 %
Bio. Ref. Interval. :
As per ADA Guidelines Guidance For Known Diabetics
Below 5.7% : Normal Below 6.5% : Good Control
5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 100 mg/dL

Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values

Please correlate with clinical conditions.

Tests Done : HBA PROFILE,HEMOGRAM

Report Remarks : Labcode:2001123223/A8193 Scan QR to verify(valid for

Dr Syeda Sumaiya [Link]
30 days from release time)
MD(Path) MBBS,MD (Biochem)

Page : 1 of 11
Processed At :

5CA-711, 3rd Floor, HRBR 2nd

Block, Hennur, Bengaluru-560043

Patient Name : ARPITA HADIMANI (60Y/F) Sample Collected on (SCT) : 20 Jan 2026 22:16
: DR PARAG MELAVANKI Sample Received on (SRT) : 20 Jan 2026 23:13
Referred By
Sample Collected At : (5800084401),Shravani clinic,Shravani clinic . 1 floor Sambrani Report Released on (RRT) : 21 Jan 2026 03:17
billading. 580007,580008 Sample Type | Barcode : EDTA Whole Blood | FD495732

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 13.2 g/dL 12.0-15.0
Hematocrit (PCV) CPH Detection 45.9 % 36.0-46.0
Total RBC HF & EI 5.3 X 10^6/µL 3.8-4.8
Mean Corpuscular Volume (MCV) Calculated 86.6 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 24.9 pq 27.0-32.0
Mean [Link]. Conc (MCHC) Calculated 28.8 g/dL 31.5-34.5
Red Cell Distribution Width - SD (RDW-SD) Calculated 44.2 fL 39.0-46.0
Red Cell Distribution Width (RDW - CV) Calculated 14 % 11.6-14.0
RED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 228.8 - *Refer Note below
MENTZER INDEX Calculated 16.3 - *Refer Note below
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 12.31 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 70.1 % 40-80
Lymphocytes Percentage Flow Cytometry 26.6 % 20-40
Monocytes Percentage Flow Cytometry 1.7 % 2-10
Eosinophils Percentage Flow Cytometry 1.1 % 1-6
Basophils Percentage Flow Cytometry 0.2 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.3 % 0.0-0.4
Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 8.6 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 3.28 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.21 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.03 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.14 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.05 X 10³ / µL 0.0-0.3
Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 352 X 10³ / µL 150-410
Mean Platelet Volume (MPV) Calculated 9.8 fL 6.5-12
Platelet Distribution Width (PDW) Calculated 10.7 fL 9.6-15.2
Platelet to Large Cell Ratio (PLCR) Calculated 23.5 % 19.7-42.4
Plateletcrit (PCT) Calculated 0.35 % 0.19-0.39
Remarks : Alert!!! Predominantly normocytic normochromic with microcytes & ovalocytes. WBCs:Mild Leukocytosis is present. Platelets:Appear
adequate in smear.
*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta Thalassemia Trait (BTT). MI >13, RDWI
>220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely to be BTT. Suggested Clinical correlation. BTT to be confirmed with HB
electrophoresis if clinically indicated.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Tests Done : HBA PROFILE,HEMOGRAM

Report Remarks : Labcode:2001123223/A8193

Dr Syeda Sumaiya
MD(Path)

Page : 2 of 11
Processed At :
5CA-711, 3rd Floor, HRBR 2nd
Block, Hennur, Bengaluru-560043

Patient Name : ARPITA HADIMANI (60Y/F) Sample Collected on (SCT) : 20 Jan 2026 22:16
: DR PARAG MELAVANKI Sample Received on (SRT) : 20 Jan 2026 23:14
Referred By
Sample Collected At : (5800084401),Shravani clinic,Shravani clinic . 1 floor Sambrani Report Released on (RRT) : 21 Jan 2026 03:15
billading. 580007,580008 Sample Type | Barcode : SERUM | FD686473

TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) E.C.L.I.A 13.1 ng/mL
Bio. Ref. Interval. :
Deficiency : <=20 ng/ml || Insufficiency : 21-29 ng/ml
Sufficiency : >= 30 ng/ml || Toxicity : >100 ng/ml

Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical for building
bone health.
Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic syndrome.
Increase in vitamin D total levels indicate Vitamin D intoxication.

Specifications: Precision: Intra assay (%CV):9.20%, Inter assay (%CV):8.50%

Kit Validation Reference : Holick M. Vtamin D the underappreciated D-Lightful hormone that is important for Skeletal
and cellular health Curr Opin Endocrinol Diabetes 2002:9(1)87-98.
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

VITAMIN B-12 E.C.L.I.A 320 pg/mL

Bio. Ref. Interval. :
Normal: 197-771 pg/ml

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs and milk. It
is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath. Vitamin-B12 is used to find
out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For diagnostic purpose, results should always be
assessed in conjunction with the patients medical history, clinical examination and other findings.

Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %

Kit Validation Reference : Thomas [Link] laborator Diagnostics : Use and Assessment of Clinical laboratory Results 1st Edition,TH
Books-Verl-Ges,1998:424-431
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

Please correlate with clinical conditions.

Tests Done : AAROGYAM C PRO WITH UTSH

Report Remarks : Labcode:2001123400/A8193

Dr Syeda Sumaiya [Link]
MD(Path) MBBS,MD (Biochem)

Page : 3 of 11
Processed At :
5CA-711, 3rd Floor, HRBR 2nd
Block, Hennur, Bengaluru-560043

Patient Name : ARPITA HADIMANI (60Y/F) Sample Collected on (SCT) : 20 Jan 2026 22:16
: DR PARAG MELAVANKI Sample Received on (SRT) : 20 Jan 2026 23:14
Referred By
Sample Collected At : (5800084401),Shravani clinic,Shravani clinic . 1 floor Sambrani Report Released on (RRT) : 21 Jan 2026 03:15
billading. 580007,580008 Sample Type | Barcode : SERUM | FD686473

TEST NAME TECHNOLOGY VALUE UNITS

TESTOSTERONE E.C.L.I.A < 2.5 ng/dL
Bio. Ref. Interval. :-

6 - 82

Clinical Significance: Clinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males.
Major causes of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,
Hypopituitarism some types of liver and kidney diseases and critical illness.

Specifications: Precision: Intra assay (%CV): 11.50 %, Inter assay (%CV): 5.70%; Sensitivity: 7 ng/dL.
Kit Validation Reference: Wilson JD Foster DW (Eds) Williams Textbook of Endocrinology 8th Edition WB Saunders Piladelphia
Pennsylvania.

Note : The Biological Reference Range mentioned is specific to the age group and gender. Kindly correlate clinically.

Please correlate with clinical conditions.

Method:- Fully Automated Electrochemiluminescence Compititive Immunoassay

Tests Done : AAROGYAM C PRO WITH UTSH

Report Remarks : Labcode:2001123400/A8193

Dr Syeda Sumaiya [Link]
MD(Path) MBBS,MD (Biochem)

Page : 4 of 11
Processed At :
5CA-711, 3rd Floor, HRBR 2nd
Block, Hennur, Bengaluru-560043

Patient Name : ARPITA HADIMANI (60Y/F) Sample Collected on (SCT) : 20 Jan 2026 22:16
: DR PARAG MELAVANKI Sample Received on (SRT) : 20 Jan 2026 23:14
Referred By
Sample Collected At : (5800084401),Shravani clinic,Shravani clinic . 1 floor Sambrani Report Released on (RRT) : 21 Jan 2026 03:15
billading. 580007,580008 Sample Type | Barcode : SERUM | FD686473

TEST NAME TECHNOLOGY VALUE UNITS

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 13.8 mg/L
Bio. Ref. Interval. :-

< 1.00 - Low Risk

1.00 - 3.00 - Average Risk
>3.00 - 10.00 - High Risk
> 10.00 - Possibly due to Non-Cardiac Inflammation

Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as
infection , active arthritis or concurrent illness.

Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk
for future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP
tests, ideally taken two weeks apart.

Kit Validation Reference:

[Link] management of laboratory date in medical practice 2003-3004, 207(2003).
[Link] : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.

Please correlate with clinical conditions.

Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Tests Done : AAROGYAM C PRO WITH UTSH

Report Remarks : Labcode:2001123400/A8193

Dr Syeda Sumaiya [Link]
MD(Path) MBBS,MD (Biochem)

Page : 5 of 11
Processed At :
5CA-711, 3rd Floor, HRBR 2nd
Block, Hennur, Bengaluru-560043

Patient Name : ARPITA HADIMANI (60Y/F) Sample Collected on (SCT) : 20 Jan 2026 22:16
: DR PARAG MELAVANKI Sample Received on (SRT) : 20 Jan 2026 23:14
Referred By
Sample Collected At : (5800084401),Shravani clinic,Shravani clinic . 1 floor Sambrani Report Released on (RRT) : 21 Jan 2026 03:15
billading. 580007,580008 Sample Type | Barcode : SERUM | FD686473

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 44.79 µg/dL
Bio. Ref. Interval. :
Male : 65 - 175
Female : 50 - 170
Method : Ferrozine method without deproteinization

TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 312.9 µg/dL

Bio. Ref. Interval. :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl
Method : Spectrophotometric Assay

% TRANSFERRIN SATURATION CALCULATED 14.31 %

Bio. Ref. Interval. :
13 - 45
Method : Derived from IRON and TIBC values

[Link]-BINDING CAPACITY(UIBC) PHOTOMETRY 268.11 µg/dL

Bio. Ref. Interval. :
162 - 368
Method : SPECTROPHOTOMETRIC ASSAY

Please correlate with clinical conditions.

Tests Done : AAROGYAM C PRO WITH UTSH

Report Remarks : Labcode:2001123400/A8193

Dr Syeda Sumaiya [Link]
MD(Path) MBBS,MD (Biochem)

Page : 6 of 11
Processed At :
5CA-711, 3rd Floor, HRBR 2nd
Block, Hennur, Bengaluru-560043

Patient Name : ARPITA HADIMANI (60Y/F) Sample Collected on (SCT) : 20 Jan 2026 22:16
: DR PARAG MELAVANKI Sample Received on (SRT) : 20 Jan 2026 23:14
Referred By
Sample Collected At : (5800084401),Shravani clinic,Shravani clinic . 1 floor Sambrani Report Released on (RRT) : 21 Jan 2026 03:15
billading. 580007,580008 Sample Type | Barcode : SERUM | FD686473

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 187 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 43 mg/dL 40-60
HDL / LDL RATIO CALCULATED 0.37 Ratio > 0.40
LDL CHOLESTEROL - DIRECT PHOTOMETRY 117 mg/dL < 100
TRIG / HDL RATIO CALCULATED 4.75 Ratio < 3.12
TRIGLYCERIDES PHOTOMETRY 206 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 4.3 Ratio 3-5
LDL / HDL RATIO CALCULATED 2.7 Ratio 1.5-3.5
NON-HDL CHOLESTEROL CALCULATED 143.5 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 41.22 mg/dL 5 - 40

Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
HD/LD - Derived from HDL and LDL values.
LDL - Direct Measure
TRI/H - Derived from TRIG and HDL Values
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
LDL/ - Derived from serum HDL and LDL Values
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
BORDERLINE HIGH
HIGH >240 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Tests Done : AAROGYAM C PRO WITH UTSH

Report Remarks : Labcode:2001123400/A8193

Dr Syeda Sumaiya [Link]
MD(Path) MBBS,MD (Biochem)

Page : 7 of 11
Processed At :
5CA-711, 3rd Floor, HRBR 2nd
Block, Hennur, Bengaluru-560043

Patient Name : ARPITA HADIMANI (60Y/F) Sample Collected on (SCT) : 20 Jan 2026 22:16
: DR PARAG MELAVANKI Sample Received on (SRT) : 20 Jan 2026 23:14
Referred By
Sample Collected At : (5800084401),Shravani clinic,Shravani clinic . 1 floor Sambrani Report Released on (RRT) : 21 Jan 2026 03:15
billading. 580007,580008 Sample Type | Barcode : SERUM | FD686473

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

ALKALINE PHOSPHATASE PHOTOMETRY 333.84 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.37 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.05 mg/dL 0 - 0.20
BILIRUBIN (INDIRECT) CALCULATED 0.32 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 23.4 U/L < 38
SGOT / SGPT RATIO CALCULATED 0.85 Ratio <2
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 27.5 U/L < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 32.4 U/L < 34
PROTEIN - TOTAL PHOTOMETRY 8.06 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.72 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 3.34 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.41 Ratio 0.9 - 2

Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Diazonium salt DPD method
BILD - Diazonium salt DPD method
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
OT/PT - Derived from SGOT and SGPT values.
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Tests Done : AAROGYAM C PRO WITH UTSH

Report Remarks : Labcode:2001123400/A8193

Dr Syeda Sumaiya [Link]
MD(Path) MBBS,MD (Biochem)

Page : 8 of 11
Processed At :
5CA-711, 3rd Floor, HRBR 2nd
Block, Hennur, Bengaluru-560043

Patient Name : ARPITA HADIMANI (60Y/F) Sample Collected on (SCT) : 20 Jan 2026 22:16
: DR PARAG MELAVANKI Sample Received on (SRT) : 20 Jan 2026 23:14
Referred By
Sample Collected At : (5800084401),Shravani clinic,Shravani clinic . 1 floor Sambrani Report Released on (RRT) : 21 Jan 2026 03:15
billading. 580007,580008 Sample Type | Barcode : SERUM | FD686473

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 11 mg/dL 7.94 - 20.07
UREA (CALCULATED) CALCULATED 23.54 mg/dL Adult : 17-43
CREATININE - SERUM PHOTOMETRY 0.41 mg/dL 0.55-1.02
UREA / [Link] RATIO CALCULATED 57.41 Ratio < 52
BUN / [Link] RATIO CALCULATED 26.83 Ratio 9:1-23:1
CALCIUM PHOTOMETRY 10.22 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 4.77 mg/dL 3.2 - 6.1
SODIUM I.S.E - INDIRECT 139.56 mmol/L 136 - 145
CHLORIDE I.S.E - INDIRECT 102.09 mmol/L 98 - 107

Please correlate with clinical conditions.

Method :
BUN - Kinetic UV Assay.
UREAC - Derived from BUN Value.
SCRE - Creatinine Enzymatic Method
UR/CR - Derived from UREA and [Link] values.
B/CR - Derived from serum Bun and Creatinine values
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method
SOD - ION SELECTIVE ELECTRODE - INDIRECT
CHL - ION SELECTIVE ELECTRODE - INDIRECT

Tests Done : AAROGYAM C PRO WITH UTSH

Report Remarks : Labcode:2001123400/A8193

Dr Syeda Sumaiya [Link]
MD(Path) MBBS,MD (Biochem)

Page : 9 of 11
Processed At :
5CA-711, 3rd Floor, HRBR 2nd
Block, Hennur, Bengaluru-560043

Patient Name : ARPITA HADIMANI (60Y/F) Sample Collected on (SCT) : 20 Jan 2026 22:16
: DR PARAG MELAVANKI Sample Received on (SRT) : 20 Jan 2026 23:14
Referred By
Sample Collected At : (5800084401),Shravani clinic,Shravani clinic . 1 floor Sambrani Report Released on (RRT) : 21 Jan 2026 03:15
billading. 580007,580008 Sample Type | Barcode : SERUM | FD686473

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 190 ng/dL 80-200

TOTAL THYROXINE (T4) E.C.L.I.A 10.6 µg/dL 4.8-12.7

TSH - ULTRASENSITIVE E.C.L.I.A 2.76 µIU/mL 0.54-5.30

Comments : ***
The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :

T3,T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay

USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Tests Done : AAROGYAM C PRO WITH UTSH

Report Remarks : Labcode:2001123400/A8193

Dr Syeda Sumaiya [Link]
MD(Path) MBBS,MD (Biochem)

Page : 10 of 11
Processed At :
5CA-711, 3rd Floor, HRBR 2nd
Block, Hennur, Bengaluru-560043

Patient Name : ARPITA HADIMANI (60Y/F) Sample Collected on (SCT) : 20 Jan 2026 22:16
: DR PARAG MELAVANKI Sample Received on (SRT) : 20 Jan 2026 23:14
Referred By
Sample Collected At : (5800084401),Shravani clinic,Shravani clinic . 1 floor Sambrani Report Released on (RRT) : 21 Jan 2026 03:15
billading. 580007,580008 Sample Type | Barcode : SERUM | FD686473

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 113 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease
<15 : Kidney Failure

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- 2021 CKD EPI Creatinine Equation

~~ End of report ~~

Tests Done : AAROGYAM C PRO WITH UTSH

Report Remarks : Labcode:2001123400/A8193 Scan QR to verify(valid for

Dr Syeda Sumaiya [Link]
30 days from release time)
MD(Path) MBBS,MD (Biochem)

Page : 11 of 11
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume: (a) any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report, (b) any claims
of any nature whatsoever arising from or relating to the performance of the requested tests as well as any claim for
indirect, incidental or consequential damages. The total liability, in any case, of Thyrocare shall not exceed the
total amount of invoice for the services provided and paid for.
v Thyrocare Discovery video link :- [Link]

EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v [Link] - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS
v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints, clinical support or feedback, write to us at customersupport@[Link]
or call us on 022-3090 0000

+ T&C Apply, #As on 5th December 2024 (Applicable for all company owned labs except Bhagalpur & Vijayawada),
* As per survey on doctors’ perception of laboratory diagnostics (IJARIIT, 2023), -Mumbai Reference Lab is CAP Accredited

Page : 3 of 3